Core Viewpoint - The company, Aedus Medical, plans to raise up to $7 million through an IPO, with a proposed share price range of $7 to $9, leading to a market valuation of approximately $87 million [1] Company Overview - Aedus Medical, established in 2003, is based in Hong Kong and operates as a medical device and software procurement company [1] - The company sells medical devices and software to distributors and medical institutions in Hong Kong and mainland China [1] Product Offerings - Aedus Medical's product portfolio includes infusion pumps, anesthetic laryngoscopes, portable X-ray machines, and automated external defibrillators [1] - The company has developed proprietary medical software, including preclinical imaging post-processing software Prim and MRI analysis software iMRIPlus [1] Financial Performance - For the 12 months ending March 31, 2025, Aedus Medical reported projected revenues of $25 million [1] IPO Details - The company intends to list on NASDAQ under the ticker symbol "AED" [1] - Maxim Group LLC is the exclusive bookrunner for this transaction [1]

Core Insights - Lumexa Imaging Holdings, Bluerock Acquisition, and Carbon Capital Partners collectively raised $913 million upon their NASDAQ debut on December 11 [1] - Lumexa Imaging Holdings opened at $18.65 per share, slightly above its offering price, and closed at $18.52, with a total market capitalization of $1.751 billion [1][4] - Lumexa Imaging reported revenues of $755 million and a net loss of $18.41 million for the nine months ending September 30, 2025 [4] New Listings - Lumexa Imaging Holdings (LMRI) raised $463 million by issuing 25 million shares at $18.50 each, with funds allocated for repaying existing loans and general corporate purposes [4] - Bluerock Acquisition (BLRKU) and Carbon Capital Partners (KBONU) also listed on the same day, raising $150 million and $300 million respectively [5] IPO Filings - Brand Meditech Limited, a Chinese company, filed for an IPO with plans to list on NASDAQ under the ticker AED, aiming to raise between $6.3 million and $8.1 million by offering 900,000 shares at $7 to $9 each [6][10] - Brand Meditech specializes in medical devices and software, including infusion pumps and portable X-ray machines, targeting various medical fields [10] Financial Data - For the fiscal years ending March 31, 2024, and 2025, Brand Meditech reported revenues of $2.619 million and $2.549 million, with net profits of $1.47 million and $1.21 million respectively [11]